Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|December 19, 2025
Pathogenic role of IFNγ from activated CD4+ T cells in lupus model mice induced by topical treatment with toll-like receptor agonist imiquimodReona Tanimura, Yuya Kondo, Ryota Sato, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2014
DNA microarray analysis of labial salivary glands in IgG4-related disease: comparison with Sjögren's syndromeHiroto Tsuboi, Yuji Nakai, Mana Iizuka, et al.
Modern Rheumatology|May 28, 2024
Clinical importance of anti-Ro52 antibody in polymyositis and dermatomyositisToshiki Sugita, Hiroto Tsuboi, Naoki Sugita, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2023
Multidrug-resistant IgA Vasculitis with Gastrointestinal Symptoms Successfully Treated with Intravenous Cyclophosphamide and Maintained with Mycophenolate MofetilHaruka Miki, Hiroto Tsuboi, Fumina Kawashima, et al.
Modern Rheumatology|April 24, 2014
Clinical features of patients with IgG4-related disease complicated with perivascular lesionsHiroshi Ebe, Hiroto Tsuboi, Chihiro Hagiya, et al.
Modern Rheumatology|November 21, 2013
Clinicopathological features of IgG4-related disease complicated with orbital involvementChihiro Hagiya, Hiroto Tsuboi, Masahiro Yokosawa, et al.
Molecular Cancer Therapeutics|January 28, 2022
Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEsMara Gilardi, Robert Saddawi-Konefka, Victoria H Wu, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2022
Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunctionHaruka Miki, William B Kiosses, Mario C Manresa, et al.
Scientific Reports|December 9, 2022
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still's diseaseMizuki Yagishita, Hiroto Tsuboi, Yuki Kuroda, et al.
Modern Rheumatology|September 12, 2014
Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeksHiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, et al.
Pageof 5